title: A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease.
authors.forename: T
authors.initials: T
authors.lastname: Flotte
authors.forename: B
authors.initials: B
authors.lastname: Carter
authors.forename: C
authors.initials: C
authors.lastname: Conrad
authors.forename: W
authors.initials: W
authors.lastname: Guggino
authors.forename: T
authors.initials: T
authors.lastname: Reynolds
authors.forename: B
authors.initials: B
authors.lastname: Rosenstein
authors.forename: G
authors.initials: G
authors.lastname: Taylor
authors.forename: S
authors.initials: S
authors.lastname: Walden
authors.forename: R
authors.initials: R
authors.lastname: Wetzel
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D002460:Cell Line; D002985:Clinical Protocols; D003550:Cystic Fibrosis / Q000150:complications / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D000229:Dependovirus / Q000235:genetics*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D015316:Genetic Therapy / Q000009:adverse effects; D005822:Genetic Vectors; D006801:Humans; D008171:Lung Diseases / Q000209:etiology / Q000628:therapy*; D008253:Macaca mulatta; D011817:Rabbits; D018570:Risk Assessment
chemical_list: C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator